Kyphoplasty is a minimally invasive, fluoroscopy-guided surgery that injects acrylic cement into vertebral bodies for fracture treatment.
Here are five observations:
1. GlobalData predicts the market will grow at a compound annual growth rate of 11.1 percent through 2023.
2. The increasing number of osteoporosis and osteopenia cases as well as the growing demand for minimally invasive and outpatient procedures will spur market growth.
3. Market barriers include the risk of cement leakage and damage of the spinal canal and nerves.
4. Further, new devices such as vertebral body stents and vertebral augmentation implants, will present a threat to the traditional vertebroplasty and kyphoplasty procedures.
5. In 2016, DePuy Synthes, Medtronic and Stryker dominated the space.
More articles on devices:
Medtronic, Implanet, J&J & more: 7 device company key notes
DePuy Synthes acquires 3D technology from Tissue Regeneration System — 5 takeaways
InVivo to present at ASIA annual meeting — 4 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
